US pursues nearly $13B of claims in Purdue Pharma opioid probes, sources say

NEW YORK — U.S. prosecutors are pursuing possible penalties of nearly $13 billion to resolve investigations of OxyContin maker Purdue Pharma after uncovering evidence of criminal and civil misconduct stemming from the company's alleged role in fueling the nation's opioid crisis, people familiar with the matter said U.S. Justice Department officials outlined additional details of...